What Do “None,” “Mild,” “Moderate,” “Severe,” and “Very Severe” Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales

Ítems similars

• Methods for implementing patient-reported outcome (PRO) measures of symptomatic adverse events in cancer clinical trials
  per: Basch, Ethan, et al.
  Publicat: (2016)
• Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
  per: Basch, Ethan, et al.
  Publicat: (2014)
• Evaluation of different recall periods for the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
  per: Mendoza, Tito R., et al.
  Publicat: (2017)
• Cognitive interviewing of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
  per: Hay, Jennifer L., et al.
  Publicat: (2013)
• Feasibility of Patient Reporting of Symptomatic Adverse Events via the PRO-CTCAE in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
  per: Basch, Ethan, et al.
  Publicat: (2017)